BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23882695)

  • 1. Compliance with occlusion therapy for childhood amblyopia.
    Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR; ;
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6158-66. PubMed ID: 23882695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A morphological study of amblyopic eyes in children failing to achieve normal visual acuity after electronically monitored long-term occlusion treatment.
    Kuhli-Hattenbach C; Koss MJ; Kohnen T; Fronius M
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2021-8. PubMed ID: 26100453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance.
    Awan M; Proudlock FA; Gottlob I
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1435-9. PubMed ID: 15790912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Amblyopia Using Personalized Dosing Strategies: Statistical Modelling and Clinical Implementation.
    Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR;
    Strabismus; 2016 Dec; 24(4):161-168. PubMed ID: 27929726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractive adaptation and efficacy of occlusion therapy in untreated amblyopic patients aged 12 to 40 years.
    Simonsz-Tóth B; Joosse MV; Besch D
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):379-389. PubMed ID: 30397791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
    Stewart CE; Moseley MJ; Stephens DA; Fielder AR
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3048-54. PubMed ID: 15326120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of optical treatment in amblyopia and validation of measuring spectacle compliance with the ODM.
    Kadhum A; Tan ETC; Wenner Y; Joosse MV; Loudon SE
    Ophthalmic Physiol Opt; 2024 Jul; 44(5):945-953. PubMed ID: 38757545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objectively monitored patching regimens for treatment of amblyopia: randomised trial.
    Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
    BMJ; 2007 Oct; 335(7622):707. PubMed ID: 17855283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized versus standardized dosing strategies for the treatment of childhood amblyopia: study protocol for a randomized controlled trial.
    Moseley MJ; Wallace MP; Stephens DA; Fielder AR; Smith LC; Stewart CE;
    Trials; 2015 Apr; 16():189. PubMed ID: 25906974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling dose-response in amblyopia: toward a child-specific treatment plan.
    Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2589-94. PubMed ID: 17525188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of unilateral amblyopia: factors influencing visual outcome.
    Stewart CE; Fielder AR; Stephens DA; Moseley MJ
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3152-60. PubMed ID: 16123414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Adherence to Glasses Wearing During Amblyopia Treatment and Improvement in Visual Acuity.
    Maconachie GD; Farooq S; Bush G; Kempton J; Proudlock FA; Gottlob I
    JAMA Ophthalmol; 2016 Dec; 134(12):1347-1353. PubMed ID: 27737444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Interocular Suppression in Amblyopic Children during Electronically Monitored Occlusion Therapy: First Insight.
    Kehrein S; Kohnen T; Fronius M
    Strabismus; 2016 Jun; 24(2):51-62. PubMed ID: 27220458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.
    Loudon SE; Polling JR; Simonsz HJ
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):176-80. PubMed ID: 12644939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic monitoring of treatment compliance in patching for amblyopia.
    Simonsz HJ; Polling JR; Voorn R; van Leeuwen J; Meester H; Romijn C; Dijkstra BG
    Strabismus; 1999 Jun; 7(2):113-23. PubMed ID: 10420216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance in amblyopia therapy: objective monitoring of occlusion.
    Fielder AR; Irwin M; Auld R; Cocker KD; Jones HS; Moseley MJ
    Br J Ophthalmol; 1995 Jun; 79(6):585-9. PubMed ID: 7626576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary report about the relation between visual acuity increase and compliance in patching therapy for amblyopia.
    Loudon SE; Polling JR; Simonsz HJ
    Strabismus; 2002 Jun; 10(2):79-82. PubMed ID: 12221485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
    Stewart CE; Fielder AR; Stephens DA; Moseley MJ
    Br J Ophthalmol; 2002 Aug; 86(8):915-9. PubMed ID: 12140215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractive adaptation in amblyopia: quantification of effect and implications for practice.
    Stewart CE; Moseley MJ; Fielder AR; Stephens DA;
    Br J Ophthalmol; 2004 Dec; 88(12):1552-6. PubMed ID: 15548811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised comparison of three tools for improving compliance with occlusion therapy: an educational cartoon story, a reward calendar, and an information leaflet for parents.
    Tjiam AM; Holtslag G; Van Minderhout HM; Simonsz-Tóth B; Vermeulen-Jong MH; Borsboom GJ; Loudon SE; Simonsz HJ
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):321-9. PubMed ID: 22820813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.